for the corporate headquarters and diagnostic lab facility located at 711. Lease agreement by and among ProPhase Diagnostics, Inc., BRG Office L.L.C. Stock Purchase Agreement by and among Nebula Genomics, Inc., the Seller Parties Named therein, Kammal Obbad in the capacity as Seller Party Representative, ProPhase Labs, Inc and.Īmended and Restated 2010 Directors Equity Compensation PlanĪmended and Restated 2010 Equity Compensation Plan Letter Agreement, dated February 28, 2022, by and between ProPhase Labs, Inc. and Unit 2 Associates L.L.C., as tenants in common, dated June 10, 2022Įmployment Agreement, dated as of May 9, 2022, by and between ProPhase Labs, Inc. Lease Agreement by and between ProPhase Diagnostics, Inc. Separation Agreement and Release, dated October 4, 2022, by and between ProPhase Labs, Inc. Unsecured Promissory Note and Guaranty issued to JXVII Trust, dated January 26, 2023Īsset Purchase Agreement by and among Stella Diagnostics Inc., Stella DX, LLC and ProPhase Labs, Inc., dated December 15, 2022 Sales Agreement dated Decembetween the Registrant and ThinkEquity LLCįorm of Incentive Stock Option Agreement pursuant to 2022 Equity Compensation PlanĬommon Stock Purchase Warrant issued to JXVII Trust, dated January 27, 2023 Inducement Option Award Agreement, dated May 9, 2022, by and between ProPhase Labs, Inc. and Unit 2 Associates L.L.C., as tenants in common and Global BioLife, Inc., dated J(effective as of July 18, 2022)įirst Amendment of Lease, dated June 10, 2022, by and between ProPhase Diagnostics, Inc.
PROPHASE LABS LICENSE
License Agreement by and between ProPhase BioPharma, Inc. (33) Browse by Contract Categoryįorm of Option Agreement pursuant to 2022 Directors Equity Compensation Planįorm of Non-Qualified Stock Option Agreement pursuant to 2022 Equity Compensation Plan
0 kommentar(er)
